PubMed ID:
27774730
Public Release Type:
Journal
Publication Year: 2017
Affiliation: Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.; Division of Nephrology, Department of Medicine, University of California Davis, Davis, California, USA.; Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Division of Nephrology, Department of Medicine, Yale School of Medicine and Yale New Haven Health System, New Haven, Connecticut, USA.; Section on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
DOI:
https://doi.org/10.1111/hdi.12489
Authors:
Lo Joan C, Beck Gerald J, Kaysen George A, Chan Christopher T, Kliger Alan S, Rocco Michael V, Chertow Glenn M
Request IDs:
20991
Studies:
Frequent Hemodialysis Network: Nocturnal Study
End-stage renal disease is associated with elevations in circulating prolactin concentrations, but the association of prolactin concentrations with intermediate health outcomes and the effects of hemodialysis frequency on changes in serum prolactin have not been examined.